Carnitine and its derivatives in cardiovascular disease

Progress in Cardiovascular Diseases

Volumn 40, Issue 3, 1997, Pages 265-286

  Arsenian, M A ^a  

^a Cape Ann Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; PROPIONYLCARNITINE;

ANGINA PECTORIS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG METABOLISM; DRUG SAFETY; DYSLIPIDEMIA; DYSPEPSIA; HEADACHE; HEART HEMODYNAMICS; HEART INFARCTION; HEARTBURN; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR DISEASE; REVIEW; VISUAL IMPAIRMENT;

EID: 0031443202     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(97)80037-0     Document Type: Article

References (242)

1. Fritz IB Action of carnitine on long chain fatty acid oxidation by liver Am J Physiol 197 1959 297 300
2. Vockley J The changing face of disorders of fatty acid oxidation Mayo Clin Proc 69 1994 249 257
3. Soop M Bjorkman O Cederblad G Influence of carnitine supplementation on muscle substrate a carnitine metabolism during exercise Eur J Appl Physiol 64 1988 2394 2399
4. Beltz SD Doering PL Efficacy of nutritional supplements used by athletes Clin Pharm 23 1993 900 908
5. Taglialatela G Navarra D Cruciani R Acetyl-L-carnitine treatment increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats Exp Gerontol 29 1994 55 66
6. Sarhan S Knoedgen B Seiler N Protection against lethal ammonia intoxication: Synergism between endogenous ornithine and L-carnitine Metab Brain Dis 9 1994 67 79
7. Pettorossi VE Draicchio F Fernandez E Pallini R The influence of L-acetylcarnitine on reinnervation of the oculomotor nerve Int J Clin Pharmacol Res 13 1993 193 199
8. 1H-NMR spectroscopy Brain Res 643 1994 92 99
9. Plioplys A Bagherpour S Kasnicka I L-carnitine as a treatment of lethargy in children with chronic neurologic handicaps Brain Dev 16 1994 146 149
10. Kuratsune H Yamaguti K Takahoshi M Acylcarnitine deficiency in chronic fatigue syndrome Clin Infect Dis 18 suppl I 1994 562 567
11. De Simone C Famularo G Tzantzoglou S Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS: Effect of oral L-carnitine AIDS 8 1994 65 660
12. Dalakas MC Leon-Monzon ME Bernardini I Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage Ann Neurol 35 1994 482 487
13. Costa M Canale D Filicori M L-carnitine in idiopathic asthenozoospermia: A multicenter study Andrologia 26 1994 155 159
14. Liedtke AJ Nellis SH Whitesell LF Mahar CQ Metabolic and mechanical effects using L-carnitine and D-carnitine in working swine hearts Am J Physiol 243 1982 H691 H697
15. Liedtke AJ Nellis SH Whitesell LF Effects of carnitine isomers on fatty acid metabolism in ischemic swine hearts Circ Res 48 1981 859 866
16. Paulson DJ Traxler J Schmidt M Protection of the ischemic myocardium by L-propionylcarnitine: Effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport and fatty acid oxidation Cardiovasc Res 20 1986 536 541
17. Paulson DJ Schmidt MJ Romens J Shug AL Metabolic and physiologic differences between zero-flow and low-flow myocardial ischemia: Effects of L-acetylcarnitine Basic Res Cardol 79 1984 551 561
18. Tassani V Cattapan F Magnanimi L Peschechera A Anaplerotic effect of propionylcarnitine in rat heart mitochondria Biochem Biophys Res Commun 15 1994 949 953
19. Micheletti R Giacalone G Conepari M Propionyl-L-carnitine prevents myocardial mechanical alterations due to pressure overload in rats Am J Physiol 266 1994 H2190 H2197
20. Shug A Paulson D Subramanian R Regitz V Protective effects of propionyl-L-carnitine during ischemia and reperfusion Cardiovasc Drug Ther 5 1991 77 84
21. Amico-Ronas M Caruso A Cutali WM Inhibitory effects of propionyl-L-carnitine on plasma extravasation induced by irritants in rodents Drugs Exp Clin Res 19 1993 213 217
22. Barbieri M Carbonin PU Cerbai E Lack of correlation between the antiarrhythmic effect of L-propionylcaritine on reoxygenation-induced arrhythmias and its electrophysiologic properties Br J Pharmacol 102 1991 73 78
23. Bertelli A Conte A Ronca G Zucchi R Effect of propionyl carnitine on cardiac energy metabolism evualted by the release of purine catabolites Drugs Exp Clin Res 17 1991 115 118
24. Reznick AC Kagan VE Ramsey R Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: The possible role of iron chelation Arch Biochim Biophys 296 1992 394 401
25. DiLisa F Menabo R Barbato R Siliprandi N Contrasting effects of propionate and propionyl-L-carnitine on energy-linked processes in ischemic hearts Am J Physiol 267 1994 H455 H461
26. Silliprandi N DiLisa F Menabo R Propionyl-L-carnitine: Biochemical significance and possible role in cardiac metabolism Caardiovasc Drugs Ther 5 suppl 1 1991 11 15
27. Liedtke AJ DeMaison L Nellis SH Effects of L-propionylcarnitine on mechanical recovery during reflow in intact heart Am J Physiol 255 1988 H169 H176
28. Molstad P The efflux of L-carnitine from cells in culture (CCL27) Biochim Biophys Acta 597 1980 166 173
29. Nakagawa T Sunamori M Suzuki A The myocardial distribution and plasma concentration of carnitine in patients with mitral valve disease Surg Today 24 1994 313 317
30. Pierpont ME Judd D Goldenberg I Myocardial carnitine in end-stage congestive heart failure Am J Cardiol 64 1989 56 60
31. Rebouche CJ Engle AG Carnitine metabolism and deficiency syndromes Mayo Clin Proc 58 1983 533 540
32. Bieber LL Carnitine Ann Rev Biochem 57 1988 261 283
33. Baker H Frank O De Angelis B Baker ER Absorption and excretion of L-carnitine during single or multiple dosings in humans Int J Vitamin Nutr Res 63 1993 22 26
34. Harper P Elwin CE Cederblad S Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects Eur J Clin Pharmacol 35 1987 555 562
35. Mitchell ME Carnitine metabolism in human subjects Am J Clin Nutr 31 1978 481 491
36. Rebouche CJ Chennard CA Metabolic fate of dietary carnitine in human adults: Identification and quantification of urinary and fecal metabolites J Nutr 121 1991 539 546
37. Marquis N Fritz I The distribution of carnitine, acetylcarnitine and carnitine acetyltransferase in rat tissue J Biol Chem 240 1965 2193 2196
38. Tanphaichitr V Leelahagul P Carnitine metabolism and human carnitine deficiency Nutrition 9 1993 246 254
39. Pola P Savi L Grilli M Carnitine in the therapy of dyslipidemic patients Curr Ther Res 27 1980 208 216
40. Indiveri C Tonazzi A Palmieri F The reconstituted carnitine carrier from rat liver mitochondria: Evidence for a transport mechanism different from that of the other mitochondrial translocators Biochim Biophys Acta 1189 1994 65 73
41. Vary TC Neely JR Characterization of carnitine transport in isolated perfused adult rat hearts Am J Physiol 244 1982 H585 H592
42. Fujisawa S Kobayashi A Hironaka Y Yamazaki N Effects of L-carnitine on the cellular distribution of carnitine and its acyl derivatives in the ischemic heart Jpn Heart J 33 1992 693 705
43. Bremer J Carnitine metabolism and function Physiol Rev 63 1983 1420 1480
44. Welling PG Thomsen JH Shug AL Tse FL Pharmacokinetics of L-carnitine in man following intravenous infusion of dl-carnitine Int J Clin Pharm Biopharm 17 1979 56 60
45. Uematsu T Itaya T Nishimoto M Pharmacokinetics and safety of L-carnitine infused IV in healthy subjects Eur J Clin Pharmacol 34 1988 213 216
46. Marzo A Candace G Corbelleta C Homeostatic equilibrium of L-carnitine family before and after IV administration of propionyl-L-carnitine in humans, dogs and rats Eur J Drug Metab Pharmacokinet 3 1991 357 363
47. Ruff LJ Miller LG Brass EP Effect of exogenous carnitine on carnitine homeostasis in the rat Biochim Biophys Acta 1073 1991 543 549
48. Brass EP Hoppel CL Hiatt WR Effect of intravenous L-carnitine on carnitine homeostasis and fuel metabolism during exercise in humans Clin Pharmacol Ther 55 1994 681 692
49. Pande SV A mitochondrial carnitine acylcarnitine translocase system Proc Nat Acad Sci USA 72 1975 883 888
50. Whitmer JT Idell-Wenger JA Rovetto MJ Neely JR Control of fatty acid metabolism in ischemic and hypoxic hearts J Biol Chem 253 1978 4305 4309
51. Shug AL Thomsen JD Folts N Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia Arch Biochem Biophys 187 1978 25 33
52. Opie LH Role of carnitine in fatty acid metabolism of normal and ischemic myocardium Am Heart J 97 1979 375 388
53. McHowat J Yamada KA Saffitz JF Corr PB Subcellular distribution of endogenous long-chain acylcarnitines during hypoxia in adult canine myocytes Cardiovasc Res 27 1993 1237 1243
54. Yamada KA McHowat J Yan GX Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia Circ Res 74 1994 83 95
55. Heathers GP Su CM Adames VR Higgins AJ Reperfusion-induced accumulation of long-chain acylcarnitines in previously ischemic myocardium J Cardiovasc Pharmacol 22 1993 854 862
56. Pande SV Blanchaer MC Reversible inhibition of mitochondrial adenosine diphosphate phosphorylation by long chain acyl coenzyme A esters J Biol Chem 246 1971 402 411
57. Idell-Wenger JA Neely JR Regulation of uptake and metabolism of fatty acids by muscle Dietschy JM Gott AM Ontko JA Disturbance in Lipid and Lipoprotein Metabolism 1978 Am Physiol Soc Baltimore, MD 269 284
58. +) stimulated ATPase of heart by fatty acids J Mol Cell Cardiol 9 1977 343 346
59. Lopaschukk GD Hansen CA Neely JR Fatty acid metabolism in hearts containing elevated levels of CoA Am J Physiol 250 1986 H351 H359
60. Katz AM Messineo FC Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium Circ Res 48 1981 1 16
61. Shug AI Shrago E A proposed mechanism for fatty acid effects on energy metabolism of the heart J Lab Clin Med 81 1973 214 218
62. Liedtke J Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart Prog Cardiovasc Dis 23 1986 321 336
63. Tanaka M Gilbert J Pappano AJ Inhibition of sodium pump by l-palmitoylcarnitine in single guinea pig ventricular myocytes J Mol Cell Cardiol 24 1992 711 719
64. + channels of guinea-pig ventricular myocytes Cardiovasc Drug Ther 7 suppl 3 1993 575 584
65. Dhalla NS Kolar F Shah KR Ferrari R Effects of some L-carnitine derivatives on heart membrane ATPases Cardiovasc Drugs Ther 1 1991 25 30
66. Kukar SS Huang WH Askari A Control of cardiac sodium pump by long-chain acyl coenzyme A J Biol Chem 262 1987 42 45
67. + ATPase by palmitylcaranitine and palmityl-CoA Biochem Biophys Res Commun 74 1979 67 684
68. 2+-ATPase and Ca transport J Biol Chem 254 1979 12404 12410
69. Huang JM Xian H Bacaner M Long-chain fatty acids activate calcium channels in ventricular myocytes Proc Natl Acad Sci USA 89 1992 6452 6456
70. Katz AM Nash-Adler P Miceli J Inhibition of calcium efflux from the sarcoplasmic reticulum by free fatty acids Circulation 59 suppl II 1979 12 20
71. Pitts BJ Tate CA Van Winkle WB Palmitylcarnitine inhibition of the calcium pumo in cardiac sarcoplasmic reticulum: A possible role in mycardial ischemia Life Sci 23 1978 391 395
72. Shug AL Shrago E Bittar N Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium Am J Physiol 228 1975 689 692
73. Shrago E Shug AL Sul H Control of energy production in myocardial ischemia Circ Res 38 suppl 1 1976 75 78
74. 2 deficient hearts Am J Physiol 247 1984 H25 H34
75. Harris RA Farmer B Ozawa T Inhibition of the mitochondrial adenine nucleotide transport system by oleoyl CoA Arch Biochem Biophys 150 1972 199 209
76. Kobayshi A Kamiya T Yamashita T Effects of glucose-insulin-potassium solution on free fatty acid metabolism in ischemic myocardium Jpn Circ J 48 1984 591 595
77. Siliprandi N DiLisa F Toninello A Biochemical derangements in ischemic myocardium: The role of carnitine G Ital Cardiol 14 1984 804 808
78. Inoue N Hirata K Akita H Yokoyama M Palmitoyl-L-carnitine modifies the function of vascular endothelium Cardiovasc Res 28 1994 129 134
79. Dainty IA Bigaud M McGrath JC Spedding M Interactions of palmitoyl carnitine with the endothelium in rat aorta Br J Pharmacol 100 1990 241 246
80. Simkhovich BZ Hale SL Ovize M Ischemic preconditioning and long-chain acyl carnitine in the canine heart Coron Artery Dis 4 1993 387 392
81. Ferrari R Cucchini F DiLisa F The effect of L-carnitine on myocardial metabolism of patients with coronary artery disease Clin Trials J 21 1984 40 50
82. Lopaschuk GD Spafford MA Davies NJ Wall SR Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia Circ Res 66 1990 546 553
83. Ferrari R Ceconi CD Cargnoni A The effect of L-propionylcarnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria Cardiovasc Drugs Ther 5 1991 57 66
84. Kobayashi A Suzuki Y Kamikawa T Effects of L-carnitine on ventricular arrhythmias after coronary reperfusion Jpn Circ J 47 1983 536 542
85. Suzuki Y Kamikawa T Kobayashi A Effects of L-carnitine on tissue levels of acyl carnitine, acyl coenzyme A and high energy phosphate in ischemic dog hearts Jpn Circ J 45 1981 687 694
86. Oliver MF Rowe MJ Vetter N Metabolic intervention Oliver MF Julian DG Donald KW Effect of Acute Ischemia on Myocardial Function 1972 Williams and Wilkins Baltimore, MD 354 362
87. Kobayashi A Fujisawa S Effect of L-carnitine on mitochondrial acyl CoA esters in the ischemic dog heart J Mol Cell Cardiol 26 1994 499 508
88. Folts JD Shug AL Koke JR Bittar N Protection of the ischemic dog myocardium with carnitine Am J Cardiol 41 1978 1209 1214
89. Nagao B Kobayashi A Yamazaki N Effects of L-carnitine on phospholipids in the ischemic myocardium Jpn Heart J 28 1987 243 251
90. Hulsmann WC Peschechera A Arrignoni-Martelli E Carnitine and cardiac interstitium Cardioscience 5 1994 67 72
91. Lopaschuk GD Wall RS Olley PM Davies NJ Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine Circ Res 63 1988 1036 1043
92. Lopaschuk GD McNeil GF McVeigh JJ Glucose oxidation is stimulated in reperfused ischemic hearts with carnitine palmitoyltransferase 1 inhibitor, etomoxir Mol Cell Biochem 88 1989 175 179
93. Lopaschuk GD Collins-Nakai R Olley PM Plasma fatty acid levels in infants and adults after myocardial ischemia Am Heart J 128 1994 61 67
94. Lopaschuk GD Spafford M Response of isolated working hearts to fatty acids and carnitine palmitoyl-transferase I inhibition during reduction of coronary flow in acute and chronically diabetic rats Circ Res 65 1989 378 387
95. Lysiak W Lilly K DiLisa F Quantitation of the effect of L-carnitine on the levels of acid-soluble short-chain acyl CoA and CoASH in rat heart and liver mitochondria J Biol Chem 263 1988 1511 1516
96. Lysiak W Toth PP Suelter CH Bieber LL Quantitation of the efflux of acylcarnitines from rat heart, brain, and liver mitochondria J Biol Chem 261 1986 13696 13703
97. Paulson DJ Shug AL Zhao J Protection of the ischemic diabetic heart by L-propionylcarnitine therapy Mol Cell Biochem 116 1992 131 137
98. Paradies G Ruggiero FM Petrosillo G Effect of aging and acetyl-L-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria FEBS 350 1994 213 215
99. Broderick TL Quinney A Lopaschuk GD Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart J Biol Chem 267 1992 3758 3763
100. Broderick TL Quinney A Barker CC Lopaschuk GD Beneficial effect of carnitine or mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation Circulation 87 1993 972 981
101. Capaldo B Napoli R DiBonito P Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients Diabetes Res Clin Pract 14 1991 191 195
102. Arenas J Huertas R Campos Y Effects of L-carnitine on the pyruvate dehydrogenase complex and carnitine palmitoyl transferase activities in muscle of endurance athletes FEBS 341 1994 91 93
103. Ronca G Ronca F Yu G Protection of isolated perfused working rat heart from oxidative stress by exogenous L-propionylcarnitine Drugs Exp Clin Res 18 1992 475 480
104. Packer L Valenza M Serbinova E Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart Arch Biochem Biophys 288 1991 533 537
105. Bertelli A Conte A Ronca G Protective effect of propionyl carnitine against peroxidative damage to arterial endothelium membranes Int J Tissue React 13 1993 41 43
106. Bertelli A Conte A Palmieri L Effect of propionyl carnitine on energy charge and adenine nucleotide content of cardiac endothelial cells during hypoxia Int J Tissue React 13 1991 37 40
107. McGarry JD Kobles-Valdes C Foster DW Role of carnitine in hepatic ketogenesis Proc Nat Acad Sci USA 72 1975 4385 4388
108. Bieber LL Choi YR Isolation and identification of aliphatic short-chain acylcarnitine from beef heart; possible role for carnitine in branched-chain amino acid metabolism Proc Natl Acad Sci USA 74 1977 2795 2798
109. (suppl) Schwartz A Cellular and molecular mechanisms involved in cardiac cell function: Effects of an antibiotic ionophors Acta Med Scand 1976 71 82
110. Suzuki Y Kamikawa T Kobayashi A Yamazaki N Protective effects of L-carnitine on the energy metabolism in ischemic myocardium J Mol Cell Cardiol 11 suppl 3 1979 29
111. Schwartz A Wood JM Allen JC Biochemical and morphologic correlates of cardiac ischemia Am J Cardiol 32 1973 46 61
112. Paulson DJ Schmidt MJ Traxler JS Improvement of myocardial function in diabetic rats after treaatment with L-carnitine Metabolism 33 1984 358 363
113. Suzuki Y Kamikawa T Yamazaki N Carnitine distribution in subepicardial and subendocardial regions in normal and ischemic dog hearts Jpn Heart J 22 1981 377 381
114. Liedtke AJ Nellis SH Neely JR Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine Circ Res 43 1978 652 661
115. Spagnoli LG Corsi M Villaschi S Myocardial carnitine deficiency in acute myocardial infarction Lancet 1 1982 1419 1420
116. Bohmer T Rydning A Solberg HE Carnitine levels in human serum in health and disease Clin Chem Acta 57 1974 55 61
117. DiLisa F Menabo R Siliprandi N L-propionylcarnitine protection in ischemic rat heart Mol Cell Biochem 88 1989 169 173
118. Nakagawa T Sunamori M Suzuki A The effect of L-carnitine on myocardial protection in cold cardioplegia followed by reperfusion Thorac Cardiovas Surg 42 1994 85 89
119. Riva E Leopaldi D Control of the cardiac consequences of myocardial ischemia and reperfusion by L-propionylcarnitine: Age-response and dose-response studies in the rat heart Pediatr Res 34 1993 465 470
120. Mouhieddine S de Leiris J Cardioprotetive effect of L-carnitine in rats submitted to permanent left coronary artery ligation Arch Int Physiol Biochem Biophys 101 1993 411 416
121. Leasure JE Kordenat K Effect of propionyl-L-carnitine on experimental myocardial infarction in dogs Cardiovasc Drugs Ther 5 suppl 1 1991 85 95
122. Liedtke AJ Nellis SH Effects of carnitine in ischemic and fatty acid supplemented swine hearts J Clin Invest 64 1979 440 447
123. Leipala JA Bhatnagar R Pineda E Protection of the reperfused heart by L-propionylcarnitine J Appl Physiol 71 1991 1518 1522
124. Sassen LM Beztarosti K Van der Giessen WJ L-propionylcarnitine increases post-ischemic blood flow but does not affect recovery of the energy charge Am J Physiol 261 1991 H172 H180
125. Bolukoglu H Eggleston AM Subramanian R Effects of propionyl-L-carnitine in chronically hypoperfused (hibernating) myocardium Cardioscience 2 1991 245 255
126. (abstr) Vick J DeFelice S Sanzari N Klein M Protective effects of carnitine in myocardial ischemia Physiologist 19 1976 402
127. Bohles H Noppeney T Akcetin Z The effect of preoperative L-carnitine supplementation on myocardial metabolism during aorto-coronary bypass surgery Curr Ther Res 30 1986 429 435
128. Corbucci GG Menichetti A Cogliatti A Metabolic aspects of acute tissue hypoxia during extracorporeal circulation and their modification induced by L-carnitine treatment Int J Clin Pharmacol Res 12 1992 149 157
129. Risson P Biasco G DiBiase M High doses of L-carnitine in acute myocardial infarction: Metabolic and antiarrhythmic effects Eur Heart J 10 1989 502 508
130. Rebuzzi AG Schiavoni G Amico CM Beneficial effects of L-carnitine in the reduction of the necrotic area in acute myocardial infarction Drugs Exptl Clin Res 10 1984 219 223
131. Thomsen JH Shug AL Yap VU Improved pacing tolerance of the ischemic human myocardium after administration of carnitine Am J Cardiol 43 1979 300 306
132. Ferrari R Cucchini F Visioli O The metabolic effects of L-carnitine in angina pectoris Int J Cardiol 5 1984 213 216
133. Reforzo G Bessone P Rebaudo F Tibaldi M Effects of high doses of L-carnitine on myocardial lactate balance during pacing-induced ischemia in aging subjects Curr Ther Res 40 1986 374 383
134. Bartels GL Remme W Pillay M Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris Am J Cardiol 74 1994 125 130
135. Kosolcharoen P Nappi J Peduzzi P Improved exercise tolerance after administration of carnitine Curr Ther Res 30 1981 753 764
136. Kamikawa T Suzuki Y Kobayashi A Effects of L-carnitine on exercise tolerance in patients with stable angina Jpn Heart J 25 1984 587 597
137. Cherchi A Lai C Angelino F Effects of L-carnitine on exercise tolerance in chronic stable angina: Multicenter, double-blind, randomized, placebo controlled crossover study Int J Clin Pharm Ther Tox 23 1985 569 572
138. Cherchi A Lai C Onnis E Propionyl carnitine in stable effort angina Cardiovasc Drugs Ther 4 1990 481 486
139. Yoshitoshi Y Yamazaki N Iimura O Efficacy of levocarnitine chloride in treatment of ischemic heart disease by the serial multistage treadmill exercise testing. A multicenter double-blind group-comparison study Jpn J Pharmacol Ther 20 1989 687 694
140. Canale C Terrachini V Biagini A Bicycle ergometer and echocardiographic study in healthy subjects and patients with angina pectoris after administration of L-carnitine: Semiautomatic computerized analysis of M-mode tracings Int J Cln Phar Ther Tox 26 1988 221 224
141. Orlando G Rusconi C Oral L-carnitine in the treatment of chronic cardiac ischemia in elderly patients Clin Trials J 23 1986 338 344
142. Cacciatore L Cerio R Ciarimboli M The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: A controlled study Drugs Exp Clin Res 17 1991 225 235
143. Davini P Bigalli A Lamanna F Boem A Controlled study on L-carnitine therapeutic efficacy in post infarction Drugs Exp Clin Res 18 1992 355 365
144. Iliceto S Scrutinio D Bruzzi P Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: The L-carnitine ecocardiografia digitalizzata infarcto miocardio (CEDIM) trial J Am Coll Cardiol 26 1995 380 387
145. Sundquist KE Vuorinen KH Peuhkurinen KJ Hassinen I Metabolic effects of propionate, hexanoate and propionylcarnitine in normoxia, ischaemia and reperfusion. Does ananaplerotic substrate protect theischaemic myocardium? Eur Heart J 15 1994 561 570
146. Duncker DJ Sassen LM Bartels GL L-propionylcarnitine does not affect myocardial metabolic or functional response to chronotropic and inotropic stimulation after repetetive ischemia in anesthetized pigs J Cardiovasc Pharmacol 22 1993 488 498
147. Gilmour RF Williams ES Farmer BB Zipes DP Effects of carnitine and atractyloside on canine cardiac electrical activity Am J Physiol 241 1981 H505 H512
148. Yamada KA Dobmeyer DJ Kanter EM Priori SG Corr PB Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium Cardiovasc Drugs Ther 5 Suppl 1 1991 67 76
149. Paulson DJ Shug AL Effects of carnitine on the ischemic arrested heart Basic Res Cardiol 77 1982 460 463
150. Hearse DJ Shattock MJ Manning AS Braimbridge MV Protection of the myocardium during ischemic arrest: Possible toxicity of carnitine in cardioplegic solutions Thorac Cardiovasc Surg 27 1980 253 258
151. Demeyere R Lormans P Weidler B Cardioprotective effects of carnitine in extense aortocornary bypass grafting: a double-blind, randomized, placebocontrolled clinical trial Anesth Analg 71 1990 520 528
152. Arsenian M New P Cafasso C Safety tolerability and efficacy of a glucose-insulin-potassium-magnesium-carnitine solution in acute myocardial infarction Am J Cardiol 78 1996 476 479
153. Brooks H Goldberg L Holland R Carnitine-induced effects on cardiac and peripheral hemodynamics J Clin Pharmacol 17 1977 561 568
154. Suzuki Y Kamikawa T Yamazaki N Effect of L-carnitine on cardiac hemodynamics Jpn Heart J 22 1980 219 225
155. Schiavoni G Pennestri F Mongiardo R Cardio-dynamic effects of L-carnitine in ischaemic cardiomyopathy Drugs Exptl Clin Res 9 1983 171 185
156. Marconi C Sassi G Carpinelli A Cerretelli P Effects of L-carnitine loading on the aerobic and anaerobic performance of endurance athletes Eur J Appl Physiol 54 1985 131 135
157. Cevese A Schena F Cerutti G Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs Cardiovasc Drug Ther 5 1991 45 56
158. Ferrari R Pasini E Condorelli E Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart Cardiovasc Drugs Ther 5 suppl 1 1991 17 23
159. Motterlini R Samaja M Tarantola M Functional and metabolic effects of propionyl-L-carnitine in the isolated perfused hypertrophied rat heart Mol Cell Biochem 116 1992 139 145
160. Chiddo A Gaglione A Musci S Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function Cardiovasc Drugs Ther 5 suppl 1 1991 107 111
161. Bartels GL Remme WJ Pillay M Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans J Cardiovasc Pharmacol 20 1992 157 164
162. Pugliese D Sabba C Ettorre G Acute systemic and splanchnic haemodynamic effects of L-carnitine in patients with cirrhosis Drugs Exp Clin Res 18 1992 147 153
163. Corbucci G Lettieri B Cardiogenic shock and L-carnitine: Clinical data and therapeutic perspectives Int J Clin Pharmacol Res 11 1991 283 293
164. Corbucci CG Locke F L-carnitine and cardiogenic shock therapy: Pharmacodynamic aspects and clinical data Int J Clin Pharmacol Res 13 1993 87 91
165. Gasparetto A Corbucci G DeBiasi R Influence of acetyl-L-carnitine infusion on hemodynamic parameters and survival of circulatory shock patients Int J Clin Pharmacol Res 11 1991 83 92
166. (suppl) Dubelaar ML Lucas CM Hulsmann WC The effect of L-carnitine on force development of the latissimus dorsi muscle in dogs J Card Surg 6 1991 270 275
167. Brass EP Scarrow AM Ruff LJ Carnitine delays rat skeletal muscle fatigue in-vitro J Appl Physiol 75 1993 1595 1600
168. Huertas R Campos Y Diaz E Respiratory chain enzymes in muscle of endurance athletes: Effect of L-carnitine Biochem Biophys Res Commun 18 1992 102 107
169. Ahmad S Robertson HT Golper TA Multicenter trial of L-carnitine in maintenance hemodialysis patients: II, Clinical and biochemical effects Kidney Int 38 1990 912 918
170. Vecciet L DiLisa F Pieralisi G Influence of L-carnitine administration on maximal physical exercise Eur J Appl Physiol 61 1990 486 490
171. Dragan GJ Vasiliu A Georgescu E Dumas I Studies concerning chronic and acute effects of L-carnitine on some biological parameters in elite athletes Rev Roum Morphol Embryol Physiol Physiologie 24 1987 23 28
172. Grieg C Finch KM Jones DA The effect of oral supplementation with L-carnitine on maximum and submaximum exercise capacity Eur J Appl Physiol 56 1987 457 460
173. Dal Negro R Pomari G Zoccatelli O Turco P Changes in physical performance of untrained volunteers: Effects of L-carnitine Clin Trials J 23 1986 242 248
174. Cooper MB Jones DA Edwards RH The effects of marathon running on carnitine metabolism and on some aspects of muscle mitochondrial activities and antioxidant mechanisms J Sports Sci 4 1986 79 87
175. DiBiase M Tritto M Pitzalis MV Electrophysiologic evaluation of intravenous L-propionylcarnitine in man Int J Caradiol 30 1991 329 333
176. Imai S Matsui K Nakazawa M Anti-arrhythmic effects of carnitine chloride and its acetyl analogue on canine late ventricular arrythmia induced by ligation of the coronary artery as related to improvement of mitochondrial function Br J Pharmacol 82 1984 533 542
177. Duan J Moffat MP Protective effects of D,L-carnitine against arrhythmias induced by lysophosphatidylcholine or reperfusion Eur J Pharmacol 192 1991 355 363
178. Kotakawa T Miyazaki Y Ogawa K Protection by carnitine against free fatty acid-induced arrhythmia in canine heart J Appl Biochem 3 1981 292 300
179. Suzuki Y Narita M Yamazaki N Effects of L-carnitine on arrhythmias during hemodialysis Jpn Heart J 23 1982 349 359
180. Carbonin PU Ramacci MT Pahor M Antiarrhythmic effects of L-propionylcarnitine in isolated cardiac preparations Cardioscience 2 1991 109 114
181. DiPalma JR Ritchie M McMichael RF Cardiovascular and antiarrhythmic effects of carnitine Arch Int Pharmacodyn 217 1975 246 250
182. Diglesi V Cantini F Bisi G L-carnitine adjuvant therapy in essential hypertension Clin Ther 5 1994 391 395
183. Stanley CA DeLeeuw S Coates PM Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake Ann Neurol 30 1991 709 716
184. Ino T Sherwood WG Benson LN Cardiac manifestations in disorders of fat and carnitine metabolism in infancy J Am Coll Cardiol 11 1988 1301 1308
185. Waber L Valle D Neill C Carnitine deficiency presenting as a familial cardiomyopathy: A treatable defect in carnitine transport J Pediatrics 101 1982 700 705
186. Pepine CJ The therapeutic potential of camitine in cardiovascular disorders Clin Ther 13 1991 3 21
187. Cederbaum SD Auestad N Bernar J Four-year treatment of systemic carnitine deficiency N Engl J Med 310 1984 1395 1396
188. Regitz V Shug AL Fleck E Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary hypertensive and valvular heart disease Am J Cardiol 65 1990 755 760
189. Pierpont ME Foker JE Pierpont GL Myocardial carnitine metabolism in congestive heart failure induced by incessant tachycardia Basic Res Cardiol 88 1993 362 370
190. Tripp ME Shug AL Plasma carnitine concentrations in cardiomyopathy patients Biochem Med 32 1984 199 206
191. Matsui S Sugita T Matoba M Urinary carnitine excretion in patients with heart failure Clin Cardiol 17 1994 301 305
192. Kobayashi A Masumura Y Yamazaki N L-carnitine treatment for congestive heart failure-experimental and clinical study Jpn Circ J 56 1992 86 94
193. Keene BW Panciera DP Atkins CE Myocardial L-carnitine deficiency in a family of dogs with dilated cardiomyopathy J Am Vet Med Assoc 198 1991 647 650
194. York CM Cantrell CR Borum PR Cardiac carnitine deficiency and altered carnitine transport in cardiomyopathic hamsters Arch Biochem Biophys 221 1983 526 533
195. Riebel DK Uboh CE Kent RL Altered coenzyme A and carnitine distribution in presure-overloaded hypertrophied hearts Am J Physiol 244 1983 H839 H843
196. Suzuki Y Masumura Y Kobayashi A Myocardial carnitine deficiency in chronic heart failure Lancet 1 1982 116
197. Challoner DR Prols HG Free fatty acid oxidation and carnitine levels in diptheritic guinea pig myocardium J Clin Invest 51 1972 2071 2076
198. Challoner DR Mandelbaum J Elliot W Protective effect of L-carnitine in experimental intoxication with diptheria toxin J Lab Clin Med 77 1971 616 628
199. Ramos AC Barrucand L Elias PR Carnitine supplementation in diptheria Indian Pediatr 29 1992 1501 1505
200. Whitmer JT L-carnitine treatment improves cardiac performance and restores high-energy phosphate pools in cardiomyopathic Syrian hamster Circ Res 61 1987 396 408
201. el Alaoui-Talibi Z Bouhaddioni N Marquec J Assessment of the cardiostimulant action of propionyl-L-carnitine on chronically volume-overloaded rat hearts Cardiovasc Drugs Ther 7 1993 357 363
202. Yang XP Samaja M English E Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overloaded cardiac hypertrophy J Cardiovasc Pharmacol 20 1992 88 98
203. Passini E Comini L Ferrari R Effect of pripionyl-L-carnitine on experimental induced cardiomyopathy in rats Am J Cardiovasc Pathol 4 1992 216 222
204. De Leonardis V Neri B Bacalli S Cinelli P Reduction of cardiac toxicity of anthracyclines by L-carnitine: Preliminary overview of clicnical data Int J Clin Pharmacol Res 2 1985 137 142
205. De Leonardis V De Scalzi M Neri B Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens Int J Clin Pharmacol Res 7 1987 307 311
206. Ghidini O Azzurro M Vita G Sartori G Evaluation of the therapeutic efficacy of L-carnitine in congestive heart failure Int J Clin Pharmacol Ther Toxicol 26 1988 217 220
207. Mancini M Rengo F Lingetti M Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure Arzneimittelforschung 42 1992 1101 1104
208. Rodrigues B Xiang H McNeill T Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats Diabetes 37 1988 1358 1364
209. Reddi AS Jyothirmayi GN DeAngelis B Effect of short- and long-term diabetes on carnitine and myoinositol in rats Comp Biochem Physiol 98 1991 39 42
210. Broderick TL St Laurent R Rousseau-Migneron S Beneficial effects of exercise training on cardiac long-chain acylcarnitine levels in diabetic rats Diabetes Res 14 1990 33 36
211. Aoshima S Fujisawa S Kobayashi A Changes in the subcellular distribution of free carnitine and its acyl derivatives in diabetic rat hearts following treatment with L-carnitine Jpn Heart J 34 1993 763 772
212. Dai S Lee S Battell M McNeill JH Cardiovascular and metabolic changes in spontaneously hypertensive rats following streptozotocin administration Can J Cardiol 10 1994 562 570
213. Piper GM Murray WJ Salhany JM Salient effects of L-carnitine on adenine-nucleotide loss and coenzyme A acylation in the diabetic rat heart perfused with excess palmitic acid Biochim Biophys Acta 803 1984 241 249
214. Piper GM Murray WJ In-vivo and in-vitro intervention with L-carnitine prevents abnormal energy metabolism in isolated diabetic rat heart: Chemical and phosphorous-31 NMR evidence Biochem Med Metab Biol 38 1987 111 120
215. Shimura S Hasegawa T Changes of lipid concentrations in liver and serum by administration of carnitine added diets in rats J Vet Med Sci 55 1993 845 847
216. Maccari F Arseni A Chiodli P L-carnitine effect on plasma lipoproteins of hyperlipemic fat-loaded rats Lipids 27 1987 1005 1008
217. Maccari F Pessotto P Ramacci MT Angelucci L The effect of exogenous L-carnitine on fat diet-induced hyperlipidemia in the rat Life Sci 36 1985 1967 1975
218. Brady LJ Knoeber M Hoppel CL Pharmacologic action of L-carnitine on hypertriglyceridemia in obese Zucker rats Metab Clin Exp 35 1986 555 562
219. Spagnoli LG Orlandi A Marino B Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits Atherosclerosis 114 1995 29 44
220. Maebashi M Kawamura N Sato M Lipid-lowering effect of carnitine in patients with type-IV hyperlipoproteinemia Lancet 2 1978 805 807
221. Bellinghieri G Savica V Barbera CM L-carnitine and platelet aggregation in uremic patients subjected to hemodialysis Nephron 55 1990 28 32
222. (suppl) Wanner C Wieland H Wackerle B Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients Kidney Int 36 1989 5264 5268
223. Wanner C Horl WH Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects Nephron 50 1988 89 102
224. Lacour B Charnard J DiGuilio S Carnitine improves lipid abnormalities in hemodialysis patients Lancet 2 1980 763 765
225. Sum CF Winocour PH Agius L Does oral L-carnitine alter plasma triglyceride levels in hypertriglyceridaemic subjects with or without non-insulin dependent diabetes mellitus Diabetes Nutr Metab Clin Exp 5 1992 175 181
226. Mondola P Santillo M DeMercato R Santangelo F The effect of L-carnitine on cholesterol metabolism in rat hepatocyte cells Int J Biochem 24 1992 1047 1050
227. Hiatt WR Nawaz D Brass F Carnitine metabolism during exercise in patients with peripheral vascular disease J Appl Physiol 62 1987 2383 2387
228. Carlin JI Reddan WG Sanjak M Hodach R Carnitine metabolism during prolonged exercise and recovery in humans J Appl Physiol 61 1986 1275 1278
229. Carter AL Lennon DL Stratman FW Increased acetyl carnitine in rat skeletal muscle as a result of high-intensity short-duration exercise FEBS 126 1981 21 24
230. Hiatt WR Regensteiner JG Hargarten ME Benefits of exercise conditioning for patients with peripheral arterial disease Circulation 81 1990 602 609
231. Brevetti G Angelini C Rosa M Muscle carnitine deficiency in patients with severe peripheral vascular disease Circulation 84 1991 1490 1495
232. Bertelli A Giovannini L Galmozzi G Bertelli AA Protective role of propionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1). serotonin and K-carrageenin Drugs Exp Clin Res 19 1993 7 11
233. Bertelli A Bertelli AA Galmozzi G Thrombosis induced by endothelin (ET-1) and carrageenin in rats treated with indomethacin and propionyl carnitine Drugs Exp Clin Res 19 1993 75 78
234. Bertelli A Giovanni L Bertelli AA Inhibition of histamine release and pressure increase induced by endothelin (ET-1) in isolated rat kidneys treated with propionyl carnitine Drugs Exp Clin Res 18 1992 349 353
235. Pola P De Martini D Gerardino L The action of propionyl-L-carnitine on the vasal endothelium: Increased t-PA synthesis and decrease in the activity of PAI-1. A preliminary study Drugs Exp Clin Res 18 1992 343 348
236. Pola P Flore R Tondi P Nolfe S Rheological activity of propionyl L-carnitine Drugs Exp Clin Res 17 1991 191 196
237. Corsico N Nardone A Lucreziotti MR Effect of propionyl-L-carnitine in rat model of peripheral arteropathy: A functional, histologic, and NMR spectroscopic study Cardiovasc Drugs Ther 7 1993 241 251
238. Brevetti G Attisano T Perna S Effect of L-carnitine on the reactive hyperemia in patients affected by peripheral vascular disease: A double-blind crossover study Angiology 10 1989 857 862
239. Brevetti G Chiariello M Ferulano G Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: A double-blind, cross-over study Circulation 77 1988 767 773
240. Brevetti G Perna S Sabba C Propionyl-L-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, muticenter study J Am Coll Cardiol 26 1995 1411 1416
241. Gossetti B Gizzi E Marini P Clinical and haemodynamic investigation on the role of acetyl carnitine in intermittent claudication Int J Clin Pharm Res 1 1981 267 271
242. Cerretelli O Marconi C L-carnitine supplementation in humans. The effects on physical performance Int J Sports Med 11 1990 1 14